LONDON — Reckitt Benckiser, which earlier this year announced plans to acquire the Mead Johnson Nutrition Co. for $17.9 billion, is considering a sale of its food business to help pay down debt ...

Reckitt Benckiser, the maker of Cillit Bang, Dettol, Gaviscon and Nurofen, has announced that it will spin-off its one-drug pharmaceutical business into a separate UK stock listing.

“The acquisition of Mead Johnson is a significant step forward in R.B.’s journey as a leader in consumer health,” said Rakesh Kapoor, chief executive officer of Reckitt Benckiser. “With ...

RB, the business formerly known as Reckitt Benckiser, also has an image problem. The company produces countless health and hygiene brands from tummy settlers to condoms to cleaning fluids.

Reckitt Benckiser and startups such as ByHeart and Bobbie are picking up customers but market-share gains could be tough to keep.